2.45%
The Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc is a UCITS compliant exchange traded fund that aims to track the MSCI ACWI IMI Disruptive technology ESG Filtered Index. The index aims to represent the performance of companies expected to derive significant revenue from areas like 3D printing, the ‘Internet of Things’, cloud computing, Fintech, digital payments, healthcare, robotics, clean energy and smart grids, and cybersecurity. The index methodology employs a set of key words of theme-related products, services and concepts built using natural language processing and data analysis techniques. These key words help identify relevant companies based on the proportion of revenue that can be linked to the Disruptive Technology theme. Annually, the expression of the high-level index objective and associated sub-themes are reviewed with the consultative input of a thematic industry expert retained by MSCI. The index is filtered based on MSCI ESG Ratings, controversy scores and certain business activities, with final stock weights based on a combined score of three fundamental metrics: 1-year sales growth, Return on Invested Capital, and % sales spent on R&D and Capex. Lyxor ETFs are efficient investment vehicles listed on exchange that offer transparent, liquid and low-cost exposure to the underlying benchmark index.
Target TER is 0.45% but has temporarily been decreased to 0.15% until September 2021.
The figures relating to [past performances / simulated past performances / past performances and simulated past performances] refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data.
Product | YTD | 1M | 3M | 6M | 1Y | 3Y | 5Y | ALL |
---|---|---|---|---|---|---|---|---|
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF | 1.24% | 3.99% | -5.02% | 18.37% | 60.8% | - | - | 60.8% |
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index | 1.58% | 3.98% | -4.67% | 18.84% | 61.62% | - | - | 61.62% |
Product | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF | - | - | - | - |
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index | - | - | - | - |
This ETF uses physical replication to track the performance of the index. As such, the holdings of the ETF reflect those of the benchmark index.
You can read more about our approach to replication in our
pragmatic guide to replication.
Name | Currency | Weight |
---|---|---|
OBI PHARMA INC | TWD | 2.56% |
DICERNA PHARMACEUTICALS INC | USD | 1.39% |
AXONICS MODULATION TECHNOLOG | USD | 1.33% |
ANAPTYSBIO INC | USD | 1.26% |
ROCK TENN COMPANY -CL A | USD | 1.19% |
EDITAS MEDICINE INC | USD | 1.18% |
CUE BIOPHARMA INC | USD | 1.16% |
BLUEBIRD BIO INC | USD | 1.14% |
Adverum Biotechnologies Inc | USD | 1.08% |
ARCUS BIOSCIENCES INC | USD | 1.04% |
Name | Listing Currency | Quantity | Weight |
---|---|---|---|
OBI PHARMA INC | TWD | 1.57m | 2.54% |
DICERNA PHARMACEUTICALS INC | USD | 173,052 | 1.46% |
AXONICS MODULATION TECHNOLOG | USD | 72,354 | 1.33% |
ANAPTYSBIO INC | USD | 184,602 | 1.3% |
CUE BIOPHARMA INC | USD | 301,840 | 1.18% |
BLUEBIRD BIO INC | USD | 121,693 | 1.18% |
ROCK TENN COMPANY -CL A | USD | 168,133 | 1.17% |
EDITAS MEDICINE INC | USD | 87,933 | 1.17% |
ARCUS BIOSCIENCES INC | USD | 115,218 | 1.17% |
Adverum Biotechnologies Inc | USD | 341,088 | 1.12% |
This funds does not use sec/lending
Name | Currency | Weight |
---|---|---|
OBI PHARMA INC | TWD | 2.56% |
DICERNA PHARMACEUTICALS INC | USD | 1.39% |
AXONICS MODULATION TECHNOLOG | USD | 1.33% |
ANAPTYSBIO INC | USD | 1.26% |
ROCK TENN COMPANY -CL A | USD | 1.19% |
EDITAS MEDICINE INC | USD | 1.18% |
CUE BIOPHARMA INC | USD | 1.16% |
BLUEBIRD BIO INC | USD | 1.14% |
Adverum Biotechnologies Inc | USD | 1.08% |
ARCUS BIOSCIENCES INC | USD | 1.04% |
Full Name | MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index |
Index Type | Performance |
Index Bloomberg Ticker | MXACDSRT |
Index Currency | USD |
Number of Index Components | 175 |
Further Information | www.msci.com |
Dividend Yield (%) | 0.45 |
USD | 72.01% |
|
EUR | 10.24% |
|
Others | 4.19% |
|
TWD | 3.84% |
|
CHF | 2.14% |
|
CAD | 1.71% |
|
JPY | 1.71% |
|
CNY | 1.49% |
|
AUD | 1.39% |
|
HKD | 1.27% |
|
Information Technology | 42.04% |
|
Health Care | 41.75% |
|
Industrials | 7.82% |
|
Utilities | 2.28% |
|
Consumer Discretionary | 2.03% |
|
Financials | 1.91% |
|
Communication Services | 1.23% |
|
Energy | 0.8% |
|
Materials | 0.13% |
|
United States | 70.35% |
Taiwan | 3.84% |
China | 3.83% |
Germany | 3.72% |
France | 2.86% |
Switzerland | 2.14% |
Canada | 1.71% |
Japan | 1.71% |
Australia | 1.39% |
Sweden | 1.27% |
Belgium | 1.18% |
Netherlands | 0.98% |
Denmark | 0.96% |
United Kingdom | 0.79% |
Puerto Rico | 0.75% |
South Korea | 0.73% |
Spain | 0.6% |
Argentina | 0.55% |
Thailand | 0.31% |
Italy | 0.26% |
Hong Kong | 0.08% |
ISIN | LU2023678282 |
UCITS | Yes |
Share Class Currency | USD |
Assets Under Management | 271.3m EUR |
Total Expense Ratio | 0.15% |
Dividend Treatment | Capitalisation |
EU-SD Status | Out of Scope |
Fund Type | SICAV |
Domicile | Luxembourg |
Replication Method | Direct (Physical) |
Sampling | No |
Securities Lending | No |
Umbrella AUM | 11,462.7m EUR |
Portfolio Managers | Raphaël Dieterlen, Salah BENAISSSA |
Financial Year End | 31/10/2021 |
Inception Date | 02/03/2020 |
Minimum Investment | 1 Share |
SFDR Classification | 8 |
DISCLAIMER: This fund includes a risk of capital loss. Investors therefore may not recover all or part of their initial investment. The redemption value of this fund may be less than the amount initially invested. In a worst case scenario, investors could sustain the loss of their entire investment. Be sure to read carefully the Key Investor Information document, and the “risk factors” section of a fund’s performance to better understand the risks involved.
Exchange | Ticker Bloomberg | Listing Currency | Currency Hedged | Listing Date | Dividend Policy | ADV 3M | ISIN | Fund AUM in CCY |
---|---|---|---|---|---|---|---|---|
LSE | DTEC LN | GBP | - | 30/04/2020 | Capitalisation | 158,346GBP | LU2023678282 | 232m GBP |
LSE | UNIC LN | USD | - | 30/04/2020 | Capitalisation | 142,107USD | LU2023678282 | 321m USD |
Xetra | DRUP GY | EUR | - | 30/04/2020 | Capitalisation | 864,332EUR | LU2023678282 | 271m EUR |
Borsa Italiana | UNIC IM | EUR | - | 30/04/2020 | Capitalisation | 1.23m EUR | LU2023678282 | 271m EUR |
SIX Swiss Ex | QBIT SW | CHF | - | 23/04/2020 | Capitalisation | 697,434CHF | LU2023678282 | 300m CHF |
Euronext | UNIC FP | EUR | - | 21/04/2020 | Capitalisation | 245,608EUR | LU2023678282 | 271m EUR |
Flow Traders |
Optiver |
Société Générale |
ETF Name | Type | Language | Publication Date | Size |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Factsheets | English | 26/02/2021 | 239 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Prospectus | English | 01/03/2021 | 2173 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
KIID | Finnish | 19/02/2021 | 168 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Annual Reports | English | 31/10/2020 | 3815 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Semi-Annual Reports | English | 30/04/2020 | 942 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
ESG | English | 28/02/2021 | 431 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Latest performance analysis | English | 10/02/2021 | 749 Ko |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc |
Sustainability-related disclosures (SFDR) | English | 09/03/2021 | 111 Ko |
Notice to Shareholders Annual general meeting of Lyxor Index Fund
Blog COVID-19’s potential impact on the new mobility ecosystem
Blog Disruptive Technology in a post-Covid world